Back
Belite Bio, Inc. 10K Form
Buy
74
BLTE
Belite Bio, Inc.
Last Price:
$188.52
Seasonality Move:
-1.52%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BLTE News And Ratings
See the #1 stock for the next 7 days that we like better than BLTE
BLTE Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $7.86 |
| Price / Book: | 25.71 |
Profitability
| EPS (TTM): | -1.91980 |
|---|---|
| Net Income (TTM): | $-62.4M |
| Gross Margin: | $-449K |
| Return on Equity: | -37.13% |
| Return on Assets: | -35.82% |
Belite Bio, Inc. Earnings Forecast
Key Belite Bio, Inc. Financial Ratios
-
Per Share Earnings over the last 5 years have been positive in 1 years.
Belite Bio, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | BLTE |
| Website: | belitebio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 34.37 |
| Quick Ratio: | 34.17 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BLTE Technical Analysis vs Fundamental Analysis
Buy
74
Belite Bio, Inc. (BLTE)
is a Buy
Is Belite Bio, Inc. a Buy or a Sell?
-
Belite Bio, Inc. stock is rated a BuyThe current Belite Bio, Inc. [BLTE] share price is $187.86. The Score for BLTE is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.